[{"Id":1234,"Language":"EN","Dictionary":"Dictionary","Audience":"Patient","TermName":"TermName","PrettyUrlName":"www.glossary-api.com","Pronunciation":{"Key":"Pronunciation Key","Audio":"pronunciation"},"Definition":{"Html":"<html><h1>Definition</h1></html>","Text":"Sample definition"},"RelatedResources":[{"Url":"https://www.google.com","Type":"External","Text":"Link to Google"},{"Url":"https://www.cancer.gov/about-cancer/treatment/drugs/bevacizumab","Type":"DrugSummary","Text":"Bevacizumab"},{"Url":"https://www.cancer.gov/types/lung/patient/small-cell-lung-treatment-pdq","Type":"Summary","Text":"Lung cancer treatment"},{"Type":"GlossaryTerm","Text":"stage II cutaneous T-cell lymphoma","Id":43966,"Dictionary":"Cancer.gov","Audience":"Patient","PrettyUrlName":"stage-ii-cutaneous-t-cell-lymphoma"}],"Media":[]}]